RAO Lang


RAO Lang


Institute of Biomedical Health Technology and Engineering

Junior Principal Investigator


  • 2020 - Present

    Shenzhen Bay Laboratory         Junior Principal Investigator

  • 2019 - 2020

    National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (NIH)         Postdoc

  • 2018 - 2019

    Simmons Comprehensive Cancer Center, UT Southwestern Medical Center         Postdoc

  • 2013 - 2018

    Wuhan University         PhD

  • 2009 - 2013

    Wuhan University         Bachelor

Research Areas

My research aims to create cutting-edge biomimetic nanotechnology and exploit them to study and solve complex biological problems that are associated with human diseases. One major research goal is to overcome the various therapeutic barriers in the treatment of cancer and viral infection. I also seek to understand the fundamental sciences at the interface of nanomedicine and biology. Overall, my research program covers a broad scope of multidisciplinary areas including chemistry, materials science, nanotechnology, biotechnology and medicine.



2016     National Scholarship, Ministry of Education of China

2016     First Prize in HUST-WHU Physics Annual Meeting

2016     Outstanding Graduate Student Pacesetters, Wuhan University

2017     Top 10 Students, Wuhan University

2017     Future Scientist Award, Chinese American Society of Nanomedicine and  Nanobiotechnology (CASNN)

2017     Hibiscus Student Academic Innovation Scholarship, Hunan Province Committee

2018     Luojia Example, Wuhan University

2018     First-Prize Academic Innovation Scholarship for Graduate Students, Wuhan University

Related News

Research on the application of membrane biomimetic materials in COVID-19 and tumor immunotherapy:



Selected Publications

1. L. Rao†, S. Xia†, W. Xu†, R. Tian, G. Yu, C. Gu, P. Pan, Q.-F. Meng, X. Cai, D. Qu, L. Lu*, Y. Xie*, S. Jiang*, and X. Chen*. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc. Natl. Acad. Sci. USA, 2020, 117, 202014352. (Featured as Cover; Highlighted by The Scientist; Chemistry Views; Inverse; Infosurhoy; Scitech Daily).

2. L. Rao†, L. Wu†, Z. Liu†, R. Tian, G. Yu, Z. Zhou, K. Yang, H.-G. Xiong, A. Zhang, G.-T. Yu, W. Sun, H. Xu, J. Guo, A. Li, H. Chen*, Z.-J. Sun*, Y.-X. Fu*, & X. Chen*. Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat. Commun., 2020, 11, 4909.

3. L. Rao†, L.-L. Bu†, L. Ma, W. Wang, H. Liu, D. Wan, A. Li, S.-S. Guo, W.-F. Zhang, X.-Z. Zhao, Z.-J. Sun*, & W. Liu*. Platelet-Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma. Angew. Chem. Int. Ed., 2018, 57, 986-991.

4. L. Rao, B. Cai, L.-L. Bu, Q.-Q. Liao, S.-S. Guo, X.-Z. Zhao, W.-F. Dong*, & W. Liu*. Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. ACS Nano, 2017, 11, 3496-3505. (Highly Cited Paper).

5. L. Rao, L.-L. Bu, B. Cai, J.-H. Xu, A. Li, W.-F. Zhang, Z.-J. Sun, S.-S. Guo, W. Liu*, T.-H. Wang, & X.-Z. Zhao. Cancer Cell Membrane-Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging. Adv. Mater.2016, 28, 3460-3466. (Highly Cited Paper).